Long QT and Brugada syndromes: from genetics to clinical management

CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia.

Cell death & disease·2013

Experimental therapy of genetic arrhythmias: disease-specific pharmacology.

Handbook of experimental pharmacology·2006

Clinical profile and genetic basis of Brugada syndrome in the Chinese population.

Hong Kong medical journal = Xianggang yi xue za zhi·2004

Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome.

European heart journal·2002

Task Force on Sudden Cardiac Death, European Society of Cardiology.

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2002